QSAR development to describe HIV-1 integrase inhibition

被引:20
|
作者
Yuan, H [1 ]
Parrill, AL [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
来源
基金
美国国家科学基金会;
关键词
human immunodeficiency virus; integrase; quantitative structure-activity relationship; inhibition; multiple linear regression;
D O I
10.1016/S0166-1280(00)00553-4
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
HIV-1 integrase(IN) is one of three viral enzymes required for replication. IN mediates integration of viral DNA into the host genome in two steps: 3'-processing and strand transfer. It is currently recognized as an important target for therapeutic development against AIDS. QSAR (Quantitative Structure-Activity Relationship) modeling was utilized to study HIV-1 integrase inhibition. QSAR models were constructed to predict the IC50 values for the two structural classes (salicyhydrazines and tyrphostins) independently and in combination. The results showed that the models for different structural classes have different dependence on the same descriptors. It suggests that salicylhydrazines and tyrphostins might have different binding sites in HIV-1 integrase. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:273 / 282
页数:10
相关论文
共 50 条
  • [1] QSAR studies of HIV-1 integrase inhibition
    Yuan, HB
    Parrill, AL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (12) : 4169 - 4183
  • [2] QSAR studies of HIV-1 integrase inhibition.
    Parrill, AL
    Yuan, HB
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U668 - U668
  • [3] Inhibition of HIV-1 integrase by hydroxocobalamin
    Weinberg, JB
    Fyfe, JA
    Sherman, PA
    [J]. BLOOD, 1995, 86 (10) : 2231 - 2231
  • [4] Novel HIV-1 Integrase Inhibitor Development by Virtual Screening Based on QSAR Models
    Guasch, Laura
    Zakharov, Alexey V.
    Tarasova, Olga A.
    Poroikov, Vladimir V.
    Liao, Chenzhong
    Nicklaus, Marc C.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (04) : 441 - 448
  • [5] QSAR analysis on benzodithiazine derivatives as HIV-1 integrase inhibitors
    Ravichandran, V
    Jain, A.
    Mourya, V. K.
    Agrawal, R. K.
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2009, 2 (03) : 15 - 22
  • [6] Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors
    Almerico, Anna M.
    Tutone, Marco
    Ippolito, Mario
    Lauria, Antonino
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (03) : 214 - 233
  • [7] QSAR analysis on benzodithiazine derivatives as HIV-1 integrase inhibitors
    Ravichandran V
    Jain A
    Mourya V.K
    Agrawal R.K
    [J]. Asian Pacific Journal of Tropical Medicine, 2009, 2 (03) : 15 - 22
  • [8] A QSAR Study on Some Series of HIV-1 Integrase Inhibitors
    Kaushik, Shikha
    Gupta, Satya P.
    Sharma, P. K.
    Anwar, Zaihra
    [J]. MEDICINAL CHEMISTRY, 2011, 7 (06): : 553 - 560
  • [9] QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors
    Gupta, Pawan
    Sharma, Anju
    Garg, Prabha
    Roy, Nilanjan
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2013, 9 (01) : 141 - 150
  • [10] HIV-1 integrase inhibition of biscoumarin analogues
    Su, Chang-Xiao
    Mouscadet, Jean-Francois
    Chiang, Chih-Chia
    Tsai, Hou-Jen
    Hsu, Ling-Yih
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (05) : 682 - 686